Literature DB >> 3474148

Lack of mitogenic effects of growth hormone on human leukemic lymphoblasts.

J Blatt, S Wenger, S Stitely, P A Lee.   

Abstract

To determine whether human growth hormone (HGH) can cause proliferation of human leukemic lymphoblasts, we studied colony formation in semi-solid medium of MOLT 4, a cell line derived from an adolescent with acute lymphoblastic leukemia (ALL). Although exposure to single doses of HGH in supraphysiologic concentrations resulted in almost two-fold increases in number of colonies compared with control samples, physiologic concentrations had no effect. Similarly, physiologic concentrations of HGH had no effect on thymidine incorporation in short-term cultures of fresh lymphoblasts from children with ALL. In addition, total white blood cell and differential counts in 14 children with isolated growth hormone deficiency were reviewed pre- and post-treatment with HGH. In no case was there evidence of in vivo lymphocytosis or blastogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474148     DOI: 10.1007/BF00716469

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Effect of pituitary hormones on carcinogenesis with 9, 10-dimethyl-1, 2-dibenzanthracene in hypophysectomized rats.

Authors:  H D MOON; C H LI; M E SIMPSON
Journal:  Cancer Res       Date:  1956-02       Impact factor: 12.701

2.  Effect of hypophysectomy on a virus-induced T-cell leukemia.

Authors:  H P Bentley; E R Hughs; R D Peterson
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay.

Authors:  M A Lesniak; P Gorden; J Roth; J R Gavin
Journal:  J Biol Chem       Date:  1974-03-25       Impact factor: 5.157

4.  Studies of leukemic cell populations in culture.

Authors:  M T Aye; Y Niho; J E Till; E A McCulloch
Journal:  Blood       Date:  1974-08       Impact factor: 22.113

5.  Effect of growth hormone on lymphocyte transformation in cell culture.

Authors:  A Astaldi; B Yalcin; G Meardi; G R Burgio; R Merolla; G Astaldi
Journal:  Blut       Date:  1973-01

6.  Hormones and the immunological capacity. 3. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse.

Authors:  N Fabris; W Pierpaoli; E Sorkin
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

7.  Bone marrow colonies: stimulation in vitro by supernatant from incubated human blood cells.

Authors:  P A Chervenick; D R Boggs
Journal:  Science       Date:  1970-08-14       Impact factor: 47.728

8.  Human leukemic cells. Effect of human growth hormone.

Authors:  L S Desai; H Lazarus; C H Li; G E Foley
Journal:  Exp Cell Res       Date:  1973-10       Impact factor: 3.905

9.  Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia.

Authors:  J Blatt; B B Bercu; J C Gillin; W B Mendelson; D G Poplack
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

10.  Possible effects of growth hormone on development of acute lymphoblastic leukaemia.

Authors:  P C Rogers; D Komp; A Rogol; H Sabio
Journal:  Lancet       Date:  1977-08-27       Impact factor: 79.321

View more
  4 in total

1.  Wilms tumour in a patient with growth hormone replacement therapy.

Authors:  T Momoi; C Yamanaka; T Yorifuji; H Sasaki; M Kaji; Y Akiyama; Y Inomata; K Tanaka; H Mikawa
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

Review 2.  Growth hormone therapy and leukaemia.

Authors:  N Stahnke; H J Zeisel
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

3.  Growth and puberty after growth hormone treatment after irradiation for brain tumours.

Authors:  A L Ogilvy-Stuart; S M Shalet
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

Review 4.  Cancer risk following growth hormone use in childhood: implications for current practice.

Authors:  Amanda L Ogilvy-Stuart; Helena Gleeson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.